Movicol and Nitrolingual drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Movicol (polyethylene glycol 3350) and Nitrolingual (nitroglycerin). Common drug interactions include headache among females and cerebrovascular accident among males.

The phase IV clinical study analyzes what interactions people have when they take Movicol and Nitrolingual. It is created by eHealthMe based on reports of 71 people who take the same drugs from the FDA, and is updated regularly.

What is Movicol?

Movicol has active ingredients of polyethylene glycol 3350. It is often used in constipation. eHealthMe is studying from 14,249 Movicol users. Check the latest studies of Movicol.

What is Nitrolingual?

Nitrolingual has active ingredients of nitroglycerin. eHealthMe is studying from 2,777 Nitrolingual users. Check the latest studies of Nitrolingual.

On Jul, 19, 2026

71 people who take Movicol and Nitrolingual together, and have interactions are studied.

Movicol and Nitrolingual drug interactions.

What are the common drug interactions of Movicol and Nitrolingual, by gender? *:

female:

Headache (pain in head)
Hyperhidrosis (abnormally increased sweating)
Hyperkalaemia (damage to or disease of the kidney)
Hypersensitivity
Hypoaesthesia (reduced sense of touch or sensation)
Hypoaesthesia oral (reduced sense of touch or sensation in mouth)
Insomnia (sleeplessness)
Leukaemia (blood or bone marrow cancer)
Macrocytosis (enlargement of red blood cells with near-constant haemoglobin concentration)
Mouth haemorrhage (bleeding from mouth)

male:

Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Pulmonary embolism (blockage of the main artery of the lung)
Anaemia (lack of blood)
C-reactive protein increased
Cardiac failure chronic
Chest discomfort
Colon cancer
Cough
Dizziness
Dysphagia (a condition in which swallowing is difficult or painful)

What are the common drug interactions of Movicol and Nitrolingual, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Dizziness
Headache (pain in head)
Malaise (a feeling of general discomfort or uneasiness)
Restless legs syndrome (a powerful urge to move your legs)
Throat tightness
Abdominal pain
Cold sweat

50-59:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Bradycardia (abnormally slow heart action)
Hypertension (high blood pressure)
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)

60+:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Fatigue (feeling of tiredness)
Head injury
Nausea (feeling of having an urge to vomit)
Pain
Pancreatitis acute (sudden inflammation of pancreas)
Periprosthetic fracture
Syncope (loss of consciousness with an inability to maintain postural tone)

What are the existing conditions these people have? *

Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 19 people, 26.76%
Sleep Disorder: 16 people, 22.54%
Pain: 15 people, 21.13%
Neuropathy Peripheral (surface nerve damage): 15 people, 21.13%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 15 people, 21.13%
Dry Eyes (lack of adequate tears): 15 people, 21.13%
Chest Pain: 11 people, 15.49%
Nausea (feeling of having an urge to vomit): 9 people, 12.68%
Asthma: 5 people, 7.04%
High Blood Cholesterol: 5 people, 7.04%

* Approximation only. Some reports may have incomplete information.

Do you take Movicol and Nitrolingual?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously